about
New Directions in the Treatment of Chronic Pain: National Pain Strategy Will Guide Prevention, Management, and Research.Alleviation of pain in painful diabetic neuropathy.Skeletal complications in cancer patients with bone metastases.Nerve growth factor: a neuroimmune crosstalk mediator for all seasons.Neurotrophic Factors: An Overview.A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors.A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia: A Review.Neurosteroids in Pain Management: A New Perspective on an Old Player
P2860
Q36557004-9EB7F9C9-3CC4-45C9-9F52-0D6083494245Q38826512-3215C390-A362-4014-A2E4-FBB265E23DA3Q38917438-D0661EF3-37ED-4EFC-81BF-372548ECA39EQ39098815-B4800898-0583-493D-8E19-3FC4D6E309BCQ47313064-A142EEFF-0573-4ED9-8B01-30A057F30FDCQ47909403-6DC322E2-A108-4710-B485-EC629B42E218Q54981810-4A91CF5F-6827-4FEB-B906-634B064B860EQ55236616-B6B50AF1-FE0A-4581-9255-54A4C0F1D943Q58586871-152B57D4-127F-4116-8BDC-0E7816A5D0C8
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
NGF/TrkA Signaling as a Therapeutic Target for Pain.
@en
type
label
NGF/TrkA Signaling as a Therapeutic Target for Pain.
@en
prefLabel
NGF/TrkA Signaling as a Therapeutic Target for Pain.
@en
P2093
P2860
P356
P1433
P1476
NGF/TrkA Signaling as a Therapeutic Target for Pain.
@en
P2093
Eri Murata
Munetaka Hirose
Yoshihiro Kuroda
P2860
P304
P356
10.1111/PAPR.12342
P577
2015-08-27T00:00:00Z